Tag: Hematology
Global Hematology Drugs Market to 2030 – Featuring Roche Holding, Novartis...
The "Hematology Drugs Global Market Opportunities And Strategies To 2030, By Type, Distribution Channel, Route Of Administration, Drug Classification, Mode Of Purchase" report...
Neue Belege für die potenzielle Anwendung von Oxbryta® (voxelotor) bei Kindern...
Analyse der Phase-2a-Studie HOPE-KIDS 1 in oraler Präsentation vorgestellt Zwei Studien mit real world Daten zeigten nachhaltige Verbesserungen des Hämoglobins mit...
New Data Supporting the Potential Use of Oxbryta® (voxelotor) in Children...
Analysis from Phase 2a HOPE-KIDS 1 Study Featured in Oral Presentation Two Real-world Data Studies Demonstrated Sustained Improvements in Hemoglobin with...
Agios Presents Positive Results from Phase 2 Study of Mitapivat in...
– Study Met Primary Endpoint; Treatment with Mitapivat Induced Hemoglobin Increase of ≥1.0 g/dL in 16 of 20 (80%) Patients During Weeks 4-12...
Imara Presents Clinical Data on IMR-687 in Sickle Cell Disease at...
Final data from 93-patient Phase 2a clinical trial show lower annualized rate of vaso-occlusive crises (VOCs) and longer time to first VOC on...
Agios Announces Updated Data from ACTIVATE and ACTIVATE-T Phase 3 Studies...
– Company Expects to File for Regulatory Approval for Mitapivat for the Treatment of Adults with PK Deficiency in the U.S. This Quarter and in...
Apellis to Present Long-Term Pegcetacoplan Data in PNH at the European...
Seven accepted abstracts, including an oral presentation, reinforce the potential of pegcetacoplan, an investigational, targeted C3 therapy, to redefine treatment for patients with...
American Oncology Network Strengthens Team with Key Leadership Appointments
Fort Myers, Fla., May 06, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON), a high-growth medical oncology provider with a...